Dynamic evolution of D-dimer level in cerebrospinal fluid predicts poor outcome in patients with spontaneous intracerebral hemorrhage combined with intraventricular hemorrhage

J Clin Neurosci. 2016 Jul:29:149-54. doi: 10.1016/j.jocn.2015.10.036. Epub 2016 Apr 3.

Abstract

The risk of mortality in patients with intracerebral hemorrhage (ICH) significantly increases when complicated by intraventricular hemorrhage (IVH). We hypothesize that serial measurement of cerebrospinal fluid (CSF) D-dimer levels in patients with both ICH and IVH may serve as an early marker of IVH severity. We performed a prospective study of 43 consecutive ICH patients combined with IVH and external ventricular drainage placement admitted in our institution from 2005-2006. IVH severity (Graeb score) and fibrinolytic activity were evaluated continuously for 7days using CT scans and CSF D-dimer levels. The primary outcome was 30day mortality. Overall 30day mortality was 26% (n=11), with eight deaths (72.7%) after 3days (D3). Graeb score and CSF D-dimer on admission (D0) were not significantly different between survivors and non-survivors. The temporal profiles of both parameters were distinctly different, with a downward trend in survivors and an upward trend in non-survivors. A mortality rate of 54% was observed between D0-D3 when both scores increased during this interval. In contrast, the mortality was only 4% when both measures decreased during this interval. Early phase (D0-D3) CSF D-dimer or Graeb score change demonstrated high sensitivity of 88% and specificity of 81% when predicting 30day mortality. Early phase CSF D-dimer change in patients with both ICH and IVH is accurate in predicting mortality and may be utilized as a cost-effective surrogate indicator of IVH severity. Serial monitoring of CSF D-dimer dynamic changes is useful for early identification of patients with hematoma progression and poor outcome.

Keywords: CSF; D-dimer; Intracerebral hemorrhage; Intraventricular hemorrhage.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / cerebrospinal fluid
  • Cerebral Ventricles*
  • Cohort Studies
  • Cost-Benefit Analysis
  • Female
  • Fibrin Fibrinogen Degradation Products / cerebrospinal fluid*
  • Humans
  • Intracranial Hemorrhages / cerebrospinal fluid*
  • Intracranial Hemorrhages / diagnostic imaging
  • Intracranial Hemorrhages / mortality
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Survival Analysis
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D